Haeggquist & Eck Issues Statement Regarding Trump University Settlement

By | 2017-05-24T20:13:05+00:00 November 18th, 2016|Class Actions, Uncategorized|

Attorneys Helen Zeldes, Alreen Haeggquist, Amber Eck and Aaron Olsen, who for nearly seven years have led the massive consumer class action litigation against Donald J. Trump and Trump University, have released the following statement regarding settlement of the matter. "We are pleased to announce that a settlement has been reached in the hard-fought class [...]

Comments Off on Haeggquist & Eck Issues Statement Regarding Trump University Settlement

Haeggquist & Eck LLP Announces Investigation of ProNAi Therapeutics, Inc. (DNAI)

By | 2017-05-24T20:12:53+00:00 October 28th, 2016|Uncategorized|

Haeggquist & Eck, LLP, a shareholder and consumer rights litigation firm has commenced an investigation into ProNAi Therapeutics, Inc. (DNAI) (“ProNAi”) relating to potential violations of federal securities laws. ProNAi is a clinical stage oncology company with a focus on pioneering a novel class of therapeutics based on its proprietary DNA interference (“DNAi”) technology platform. [...]

Comments Off on Haeggquist & Eck LLP Announces Investigation of ProNAi Therapeutics, Inc. (DNAI)

Haeggquist & Eck Announces Investigation of KemPharm, Inc.

By | 2017-05-24T20:13:47+00:00 September 30th, 2016|Uncategorized|

Haeggquist & Eck, LLP has commenced an investigation into (“KemPharm”) (NASDAQ: KMPH) to determine whether KemPharm and its Officers and Directors have violated the federal securities laws. KemPharm is a clinical-stage specialty pharmaceutical company, discovers and develops new proprietary prodrugs in the United States. KemPharm was founded in 2006 and is headquartered in Coralville, Iowa. On [...]

Comments Off on Haeggquist & Eck Announces Investigation of KemPharm, Inc.

Haeggquist & Eck Announces Investigation of INSYS Therapeutics, Inc.

By | 2017-05-24T20:14:29+00:00 June 30th, 2016|Uncategorized|

Haeggquist & Eck, LLP has commenced an investigation into possible violations of the federal securities laws by certain officers and directors at INSYS Therapeutics, Inc. (“Insys” or the “Company”) (NASDAQ: INSY). Insys is a specialty pharmaceutical company that develops and commercializes supportive care products primarily designed to assist patients with pain management. Insys’s core product and [...]

Comments Off on Haeggquist & Eck Announces Investigation of INSYS Therapeutics, Inc.

Haeggquist & Eck Investigates Undisclosed Hotel Resort Fees

By | 2017-05-24T20:15:05+00:00 May 24th, 2016|Class Actions, Uncategorized|

Have you ever been charged mandatory resort fees that were not adequately disclosed? Haeggquist & Eck, LLP is investigating possible claims against major hotel and resort chains for charging undisclosed and mandatory resort fees of $25 or more per day. These hotel fees are most prevalent in Hawaii, California, Las Vegas, Nevada and Orlando, Florida. [...]

Comments Off on Haeggquist & Eck Investigates Undisclosed Hotel Resort Fees

Haeggquist & Eck Announces Investigation of Natera, Inc.

By | 2017-05-24T20:15:50+00:00 April 19th, 2016|Uncategorized|

Haeggquist & Eck, LLP, a shareholder and consumer rights litigation firm, has commenced an investigation into Natera, Inc. (“Natera”) (NASDAQ: NTRA) to determine whether Natera and its Officers and Directors have violated the federal securities laws under the Securities Exchange Act of 1934. Shareholders who have suffered losses on their investment in Natera shares are [...]

Comments Off on Haeggquist & Eck Announces Investigation of Natera, Inc.

Haeggquist & Eck Announces Investigation of PTC Therapeutics, Inc.

By | 2017-05-24T20:16:24+00:00 February 24th, 2016|Uncategorized|

Haeggquist & Eck, LLP has commenced an investigation into PTC Therapeutics, Inc. (“PTC” or the “Company”) (NASDAQ: PTCT) to determine whether PTC Therapeutics and its Officers and Directors have violated the federal securities laws under the Securities Exchange Act of 1934. Shareholders who have suffered losses on their investment in PTC shares are encouraged to contact [...]

Comments Off on Haeggquist & Eck Announces Investigation of PTC Therapeutics, Inc.

Haeggquist & Eck Files Class Action Lawsuit Against El Pollo Loco

By | 2017-05-24T20:21:50+00:00 August 26th, 2015|Securities Class Actions/ Shareholder Derivative Actions|

On August 24, 2015, Haeggquist & Eck, LLP and Robbins Geller Rudman & Dowd LLP filed a complaint alleging violations of the federal securities laws by El Pollo Loco Holdings, Inc. and certain of its officers and/or directors. The class action was commenced in the United States District Court for the Central District of California on [...]

Comments Off on Haeggquist & Eck Files Class Action Lawsuit Against El Pollo Loco

Overcharged by Whole Foods?

By | 2017-05-24T20:25:25+00:00 June 25th, 2015|Consumer, Consumer Class Actions|

Multiple government entities have and/or are investigating Whole Foods for pricing violations.  In fact, after a statewide investigation found widespread pricing violations at Whole Foods Markets in California, in 2014 the company settled with three California cities and agreed to pay $800,000 in civil penalties. Now, the New York City Department of Consumer Affairs has [...]

Comments Off on Overcharged by Whole Foods?

ZHE Files Class Action Lawsuit Against Massage Envy

By | 2015-01-08T10:30:21+00:00 September 26th, 2013|Uncategorized|

Zeldes Haeggquist & Eck, LLP has filed a class action lawsuit against Massage Envy on behalf of massage therapists and estheticians in California. The complaint alleges that Massage Envy’s compensation plan violates California’s wage and hour laws by unlawfully averaging its non-exempt employees’ compensation. Massage Envy’s policy mandates that employees are paid on a piece-rate [...]

Comments Off on ZHE Files Class Action Lawsuit Against Massage Envy